Work Notes: Immune Cell Therapy and Japan's Role in Cancer Treatment

• January 28, 2016
• Reading time: 1 minute

Lin Chenglong explains: "Immune cell therapy is straightforward in principle, but the cultivation process requires rigorous monitoring and careful selection of the right immune cells for growth. For example, some clinics in the market claim to offer NK (natural killer) cell infusion therapy for cancer — but this has been proven to be ineffective. Japan is the fastest-developing country in Asia in this field. Japanese hospitals are already combining immune cell therapy after surgery, chemotherapy, and radiotherapy in cancer patients to eliminate residual cancer cells."

"The best treatment environment, we believe, is in Taiwan — no need to travel far, avoiding the burden on patients and families. If finances and physical condition allow, visiting Japan for medical tourism combined with immune cell therapy is also a worthwhile option. But we mainly want to remind everyone: this type of therapy is supplementary only, and the efficacy of conventional treatments — surgery, chemotherapy, and radiotherapy — should always come first."

Regarding the mention of "Kyuryumi" in the article — that should clearly be "Kurume" (久留米)! That appears to be a typo by the journalist. Information on how to apply to that hospital and key considerations can be found on our website at http://www.medicalsupporter.org, which is updated regularly with information on medical institutions and clinical trial news. Simply put, what we can do is help ease the anxiety of seeking treatment abroad, and provide a relaxed, stress-free medical journey to Japan.

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Figure 1

Figure 2

Figure 3

Figure 4